Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2008
10/09/2008US20080249285 Method For Affinity Purification
10/09/2008US20080249284 Gene encoding labyrinthin, a marker for cancer
10/09/2008US20080249083 isolated nucleic acids coding for novel glutaminyl-peptide cyclotransferase-like proteins (QPCTLs); isoenzymes; useful for the discovery of new therapeutic agents, for measuring cyclase activity; Alzheimer's disease, Familial British Dementia, Familial Danish Dementia, Down Syndrome, Huntington's disease
10/09/2008US20080249057 Protein kinase C as a target for the treatment of respiratory syncytial virus
10/09/2008US20080249042 cultured prokaryotic or eukaryotic cell transformed or transfected with expression construct; vectors; treating retinal disease or blindness
10/09/2008US20080249027 Heptapeptide having the sequence of CHEASQC; Multiple Sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis
10/09/2008US20080249013 Immunogenic fragment of a Cripto fusion protein that is reactive with an antibody or T-cell that reacts with a given polypeptide sequence; polynucleotides, expression vectors, host cells, T-cell lines; diganosis, prevention, treatment of lung, colon, colorectal and breast cancers
10/09/2008US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions
10/09/2008US20080248972 Laminating a protein non-adsorptive substance with a negative charge on a substrate surface with a positive charge; modifying the protein non-adsorptive surface into a protein adsorptive surface; and adsorbing a protein in the locally modified region
10/09/2008US20080248959 Polypeptide with amino acid sequence including exogenous glycosylate sequence; libraries
10/09/2008US20080248588 Shrimp allergen, anti-shrimp allergen antibody, and use thereof
10/09/2008US20080248566 Matriptase, a serine protease and its applications
10/09/2008US20080248538 From Pseudomonas putida or Pseudomonas marginalis strains; probes
10/09/2008US20080248531 Preparation of fully human antibodies
10/09/2008US20080248529 Expression vector comprising nucleotide sequences coding lymphocyte surface protein specific immunoglobulin for use in treatment of cell proliferative, inflammatory and autoimmune diseases
10/09/2008US20080248528 Erythrovirus and its applications
10/09/2008US20080248509 Method for diagnosis of alzheimer's disease with determination of lasp-1 immunoreactivity
10/09/2008US20080248502 Using coxsackie virus and adenovirus receptor (CAR) specific immunoglobulin for treatment and prevention of contact dermatitis
10/09/2008US20080248496 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
10/09/2008US20080248494 Diagnosing menopause via follicle stimulating hormone specfic immunoglobulins
10/09/2008US20080248491 Biomarker fragments for the detection of human bnp
10/09/2008US20080248490 Tyrosine phosphorylated leukemia-related signaling protein specific immunoglobulin for use as evaluative tools in diagnosing/predicting cell proliferative disorders; protein phosphorylation and cancer detection
10/09/2008US20080248477 Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor
10/09/2008US20080248476 Using presence of single nucleotide polymorphism in fibronectin gene as evaluative indicator of heart disorders
10/09/2008US20080248468 Using vectors comprising RNA interfering sequences to control geneic expression in cells; utilizing nerve growth factor receptor as biomarker to confirm transfection
10/09/2008US20080248462 Using peptidase as evaluative tool in identifying modulators for prevention and treatment of cardiovascular, endocrinological, metabolic, cell proliferative, inflammatory, gastrointestinal, blood, respiratory, nervous system, urogenital and reproduction disorders
10/09/2008US20080248053 Antibody-drug conjugates; Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal-Val-Dil-Dap-Phe (MMAF); cancer; autoimmune diseases
10/09/2008US20080248051 Monomethylvaline compounds capable of conjugation to ligands
10/09/2008US20080248050 Meta-specific vaccine, method for treating patients immunized with meta-specific vaccine
10/09/2008US20080248049 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of leukemia; immunotherapy
10/09/2008US20080248047 Immunoglobulin mixture for use in treatment and prevention of cell proliferative and inflammatory disorders
10/09/2008US20080248045 Polypeptides having a triggering nk activity and biological applications
10/09/2008US20080248044 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination
10/09/2008US20080248043 Antibodies to SARS coronavirus
10/09/2008US20080248042 Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc
10/09/2008US20080248041 Using membrane protein as evauluative tool in identifying modulators for prevention and treatment of neuropathic pain and nervous system disorders
10/09/2008US20080248040 Nucleotide sequences coding membrane protein segments for use in identifying modulators for prevention and treatment of epilepsy, cancer, pain and sleep disorders
10/09/2008US20080248038 Combination of an anti ED-B fibronectin domain antibody and an anti-EGFR-antibody
10/09/2008US20080248037 Death receptor-5 (DR-5) specific immunoglobulin for use in treatment and prevention of cell proliferative and immune related disorders
10/09/2008US20080248036 Treatment with anti-vegf antibodies
10/09/2008US20080248031 Cell surface molecule mediating cell adhesion and signal transmission
10/09/2008US20080248029 Prevention and treatment of amyloidogenic diseases
10/09/2008US20080248028 Immunoadhesin comprising modified Fc gamma R segment for use as targeting diagnostic and/or therapeutic in treatment of cell proliferative disorders
10/09/2008US20080248026 PTEN/Akt methods and compositions relating to BMP
10/09/2008US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein
10/09/2008US20080248020 Variant lyase for use in treatment and prevention of cell proliferative disorders
10/09/2008US20080248011 Immunoglobulin for identifying cells expressing monocyte integral membrane proein (HIDE-1); inducing propagation of dendritic cell for use in treatment of autoimmune, tumor and organ rejection disorders
10/09/2008US20080248008 Transferase inhibitory mimetic for use in treatment and prevention of immunosuppressive, cell proliferative and autoimmune disorders
10/09/2008US20080248007 Nucleotide sequences coding protein associated with immune response for use in identifying modulators for prevention and treatment of immunodeficiency, autoimmue and inflammatory disorders
10/09/2008US20080247991 Solution Additives For the Attenuation of Protein Aggregation
10/09/2008US20080247955 Detecting secreted phosphoprotein-1 and/or biomarkers; autoimmune diseases; antibodies; RNA interference
10/09/2008US20080247951 Angiogenesis inhibition
10/09/2008US20080247950 Proteases of human kallikrein 2 (hK2); tissue imaging
10/09/2008US20080247945 Interleukins; cytokines; monoclonal antibodies; bioconjugation; toxic shock syndrome
10/09/2008US20080247944 Human monoclonal antibodies; encoded by nucleic acids; anticancer agents
10/09/2008CA2683370A1 Cross-species-specific binding domain
10/09/2008CA2682851A1 A novel antigen associated with the neovasculature of tumour metastases
10/09/2008CA2682626A1 Cross-species-specific bispecific binders
10/09/2008CA2682382A1 Non-fucosylated antibodies
10/09/2008CA2682292A1 Antibody formulation
10/09/2008CA2682266A1 Treatment of hodgkins lymphoma
10/09/2008CA2682155A1 Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
10/09/2008CA2682093A1 Antibodies, methods and kits for diagnosing and treating melanoma
10/09/2008CA2681974A1 Bispecific antibodies and methods for production thereof
10/09/2008CA2681790A1 Composition of labeled and non-labeled monoclonal antibodies
10/09/2008CA2681752A1 Crystalline anti-human 1l-12 antibodies
10/08/2008EP1978097A1 Regulation of transcription factor, NF-IL6/LAP
10/08/2008EP1978035A1 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/08/2008EP1978034A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same
10/08/2008EP1978033A2 Human antibodies derived from immunized xenomice
10/08/2008EP1978032A2 Binding molecules
10/08/2008EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same
10/08/2008EP1977762A1 Ctgf as target for the therapy of diabetic nephropathy
10/08/2008EP1977755A1 Shrimp allergen antishrimp allergen antibody and use thereof
10/08/2008EP1977247A2 Methods for diagnosing and treating prostate cancer
10/08/2008EP1976991A1 Fusion proteins that contain natural junctions
10/08/2008EP1976988A1 C-terminal exon 5.4 of runx1/aml1
10/08/2008EP1976987A1 Novel cancer-associated antigen
10/08/2008EP1976976A2 Treatment of neuroaids using inhibitors of glycogen synthase kinase (gsk)-3
10/08/2008EP1976974A2 Pneumococcal serotypes
10/08/2008EP1976886A1 Means and methods for the treatment of tumorous diseases
10/08/2008EP1976885A2 Pharmaceutical antibody compositions with resistance to soluble cea
10/08/2008EP1976884A2 Anti-ephrinb2 antiboies and methods using same
10/08/2008EP1976883A2 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
10/08/2008EP1976882A2 Ligands that bind il-4 and/or il-13
10/08/2008EP1976881A2 Chimeric and humanised anti-human il-13 antibodies
10/08/2008EP1976880A1 Pharmaceutical compositions with resistance to soluble cea
10/08/2008EP1976879A2 Ligands that have binding specificity for vegf and/or egfr and methods of use therefor
10/08/2008EP1976878A2 Sequence of stro-1 antibody variable region
10/08/2008EP1976877A2 Monoclonal antibodies against amyloid beta protein and uses thereof
10/08/2008EP1976594A2 Compositions and methods of use for antibodies of dickkopf-1 and/or -4
10/08/2008EP1784643A4 Homogeneous enzyme immunoassay for oral fluid
10/08/2008EP1611247B1 Cyp2s1 as target for diagnosis and therapy of skin diseases
10/08/2008EP1507795B1 Tumour-associated peptides that bond to mhc molecules
10/08/2008EP1399580B1 Secretion of proteins by encapsulated cells
10/08/2008EP1394263B1 Methods for detection and separation of undifferentiated hepatic cells using dlk
10/08/2008EP1349870B1 Compositions for the therapy and diagnosis of ovarian cancer
10/08/2008EP1262548B1 Polypeptide inducing apoptosis
10/08/2008EP1199565B1 Diagnostics and remedies for diseases with participation of macrocytes/macrophages
10/08/2008EP1071779B1 Vertebrate patched-2 protein
1 ... 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 ... 1494